Shiseido (OTCMKTS:SSDOY) and Acura Pharmaceuticals (OTCMKTS:ACUR) Critical Analysis

Acura Pharmaceuticals (OTCMKTS:ACUR) and Shiseido (OTCMKTS:SSDOY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Insider and Institutional Ownership

0.0% of Shiseido shares are owned by institutional investors. 20.2% of Acura Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Acura Pharmaceuticals and Shiseido”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acura Pharmaceuticals	$1.56 million	0.20	-$880,000.00	N/A	N/A
Shiseido	$6.94 billion	1.37	$153.49 million	$0.17	139.53

Shiseido has higher revenue and earnings than Acura Pharmaceuticals.

Volatility and Risk

Acura Pharmaceuticals has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Shiseido has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500.

Profitability

This table compares Acura Pharmaceuticals and Shiseido’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acura Pharmaceuticals	N/A	N/A	N/A
Shiseido	1.03%	1.54%	0.77%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Acura Pharmaceuticals and Shiseido, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acura Pharmaceuticals	0	0	0	0	N/A
Shiseido	0	0	0	0	N/A

Summary

Shiseido beats Acura Pharmaceuticals on 7 of the 9 factors compared between the two stocks.

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

About Shiseido

Shiseido Company, Limited engages in the production and sale of cosmetics in Japan and internationally. The company offers fragrances; and skincare and makeup products. It also engages in the restaurant and food, and retail businesses; and operates beauty salons. In addition, the company operates and supports SABFA, a professional hair makeup training school. Further, it offers childcare facilities. The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.